Who is sponsoring NCT03885869?

NCT03885869 is sponsored by Ankara Yildirim Beyazıt University.

What drugs are being tested in NCT03885869?

Interventions in NCT03885869: Ankle Joint Position Sensation Evaluation, Knee Joint Position Sensation Evaluation, The Evaluation of Plantar Sensation, The Evaluation of Balance, Evaluation of Dual Task Performance, General Evaluation Form.

What condition does NCT03885869 study?

NCT03885869 studies Type 2 Diabetes Mellitus, Balance.

Is NCT03885869 still recruiting?

NCT03885869 is currently completed. Last updated 26 January 2021.

Last reviewed 2021-01-26 · How we verify

NCT03885869

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Joint Position Sense, Plantar Sensation, Balance and Dual Task Performance in Individuals With Type 2 Diabetes

Completed Last updated 26 January 2021

What this trial tests

trial testing Ankle Joint Position Sensation Evaluation in Type 2 Diabetes Mellitus in 46 participants. Completed in 25 March 2020.

Timeline

25 March 2019

Primary endpoint
25 August 2019

25 March 2020

Quick facts

Lead sponsor	Ankara Yildirim Beyazıt University
Status	Completed
Study type	OBSERVATIONAL
Enrollment	46
Start date	25 March 2019
Primary completion	25 August 2019
Estimated completion	25 March 2020
Sites	1 location across Turkey (Türkiye)

Drugs / interventions tested

Ankle Joint Position Sensation Evaluation
Knee Joint Position Sensation Evaluation
The Evaluation of Plantar Sensation
The Evaluation of Balance
Evaluation of Dual Task Performance
General Evaluation Form

Conditions studied

Type 2 Diabetes Mellitus — all drugs for Type 2 Diabetes Mellitus →
Balance — all drugs for Balance →

Sponsor

Ankara Yildirim Beyazıt University

Who can join

Adults 30 to 65, any sex, with Type 2 Diabetes Mellitus or Balance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Diabetes is a chronic disease characterized by hyperglycemia, which occurs when insulin is inadequate or the body's produced insulin cannot be used effectively, but according to the World Health Organization 2016 Global Report on Diabetes, it is an important public health problem that is one of the four priority non-infectious diseases. In addition to high mortality rates caused by diabetes-related complications, it is known that it can cause low quality of life and many additional problems in individuals. These complications and damage, which may be caused by diabetes, may result in reduced blood flow combined with neuropathy; As a result, foot ulcers, infections and consequently the need for amputation may increase. In addition to the additional complications caused by diabetic neuropathy, protective plantar sensory loss and decreased joint position have been reported in the literature. In particular, investigators did not find any comprehensive studies examining the relationship between these sensory changes and the dual task performance in diabetic subjects. In this study, investigators aimed to investigate the relationship between joint position sense, plantar sensation, balance and dual task performance in individuals with type 2 diabetes and to contribute to the literature with evidence-based, objective results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Type 2 Diabetes Mellitus

Currently open trials in the same condition.

NCT07351058 — A Clinical Study to Evaluate the Effects of RO7795068 in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · recruiting
NCT07373938 — Carotid Wall Texture as a Cardiovascular Risk Biomarker in Type 2 Diabetes Mellitus · recruiting
NCT07433062 — A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With · Phase 1 · recruiting
NCT07276776 — An Evaluation of the Omnipod® M System in Adults With Type 2 Diabetes · NA · active not recruiting
NCT07232537 — An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic · recruiting

Other Ankara Yildirim Beyazıt University trials

Trials by the same sponsor.

NCT07530835 — Occlusal Changes After Modified Hall Technique in Molars Affected by Molar-Incisor Hypomineralization · NA · not yet recruiting
NCT07496853 — Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke · NA · recruiting
NCT07441668 — Comfort Intervention in PICU Children · NA · not yet recruiting
NCT07431151 — Effects of Intensive Virtual Reality-Based Balance and Gait Training on Activity Performance and Quality of Life in Suba · NA · recruiting
NCT07247903 — The Impact of Patient Education Delivered Through Virtual Reality · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03885869 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ankara Yildirim Beyazıt University
Last refreshed: 26 January 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03885869.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing